Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol combined with different analgesics for painless gastroscopy
ChiCTR2100052985Phase 4Recruiting
- Sponsor
- Huai'an First People's Hospital
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, remifentanil, nalbuphine, oxycodone, dezocine and 3 more in Digestive tract dysfunction (8 arms), sponsored by Huai'an First People's Hospital. Primary endpoint: Effective sedation during diagnosis and treatment. Started Nov 2021; status: recruiting.
02
Drugs
propofolremifentanilnalbuphineoxycodonedezocine
03
Conditions
Digestive tract dysfunction
Beyond the preview
Go deeper on ChiCTR2100052985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052985.